ARM Webinar: Critical Supply Chain & Logistics Considerations for Cell and Gene Therapy Management
August 14, 2024 | 11am – 12pm ET
This webinar, moderated by Cryoport Systems’ CEO Mark Sawicki, will bring industry leaders together to discuss the unique challenges and critical considerations in managing the temperature-controlled supply chain and logistics for CGTs. The conversation will highlight the complexities, regulatory requirements, and innovations necessary to ensure the safe and efficient delivery of these advanced therapies.
Speakers:
Mark Sawicki, Ph.D., CEO, Cryoport Systems (Moderator)
Natalie Sacarakis, Head of Cell and Gene Therapy Logistics, IQVIA Cell and Gene Therapy Center of Excellence
Narinder Singh, Chief Technical Officer, Arcellx
The Cryoport Team
-
Mark Sawicki
CEO, Cryoport Systems
About Cryoport Systems
Cryoport Systems is the life science industry’s most trusted provider of temperature-controlled logistics cand supply chain solutions, serving fertility organizations around the world. Over the past two decades, Cryoport Systems has transported over 800,000 domestic and international shipments.
About the Webinar
The Alliance for Regenerative Medicine (ARM) presents a captivating webinar series featuring distinguished executive leaders at the forefront of the cell and gene therapy sector. This engaging series is designed to shed light on the latest advancements, challenges, and transformative discussions shaping the future of regenerative medicine. Check back often as more webinars will be added to the schedule.
Let’s Connect
Interested in setting up a time to talk with our team of experts? Looking to follow up on a recent presentation or booth conversation? We’d love to hear from you! Fill out the form below and our team will be in touch.